Global Renal Biomarker Market By Biomarker Type (Functional Biomarkers (Serum Creatinine, Blood Urea Nitrogen (BUN) and Estimated Glomerular Filtration Rate (eGFR)), Upregulated Proteins (Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Cystatin C, Interleukin-18 (IL-18) and Others) and Others), By Technique (Immunoassays, Mass Spectrometry, Point-of-Care Tests, Enzyme-Linked Immunosorbent Assay (ELISA), Molecular Diagnostics and Others), By End-User (Hospitals, Diagnostic Laboratories, Academic & Research Institutes and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Global Renal Biomarker Market size is expected to be worth around US$ 3.0 Billion by 2034 from US$ 1.4 Billion in 2024, growing at a CAGR of 7.9% during the forec...